Biktarvy Sales Increased 28% Year-Over-Year to $2.6 billionOncology Sales Increased 71% Year-Over-Year to $527 millionFOSTER CITY, Calif. (BUSINESS WIRE) #Earnings Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter of 2022.“This was a very strong quarter for Gile.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Deborah Telman will join the company as Executive Vice President, Corporate Affairs and General Counsel, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day. Ms. Telman will assume .
Ms. Telman will assume responsibility for Gilead’s legal and corporate affairs function, which includes government and policy, and public affairs. Ms. Telman will start in her new role August 1, 2022. She will also become Corporate Secretary of Gilead. Ms.